Dutch-based Future Food Fund announces first close of FFF II fund at €20M: Know more
Future Food Fund, a Dutch specialist food and agri venture capital fund, announced the first close of its second fund, FFF II, at…
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
Future Food Fund, a Dutch specialist food and agri venture capital fund, announced the first close of its second fund, FFF II, at…
Update: As of April 14, 2023, Somnox has exceeded its crowdfunding goal of €750K and has received a total of €1.1M in funding from 590 investors.
Paris-based Inato, a platform that makes clinical trials more accessible, announced on Wednesday, March 29, that it has raised $20M…
Eindhoven-based Sirius Medical, a surgical marker navigation company, announced that it has secured €12M in a Series B round of funding led…
Munich-based deepc, a medtech company, announced on Tuesday, March 28, that it has secured €12M in a Series A round of funding led by Sofinnova Partners with participation from Bertelsmann Investments and Winning Mindset Ventures.
Helsinki-based MVision AI, a medtech company, announced on Thursday that it has secured €5.4M in a post-Seed funding round led by Sweden-based J12 Ventures and Finland-based Voima Ventures.
Switzerland and -Germany-based AERA Health, a preventive health startup, announced on Monday that it has raised €4M in a pre-seed round of funding from former Amazon Consumer CEO Jeff Wilke, Logitech’s President & CEO Bracken Darrell, Neworld.Global, Korify Capital, and Evoleen.
Aarhus, Denmark-based Teitur Trophics, a biotech company, announced on Tuesday, March 14, that it has secured €28M in a Series A round of funding co-led by Sunstone Life Science Ventures and Sound Bioventures.
HelloSelf, a London-based digital platform, announced on Tuesday, March 14, that it has raised $20M (approximately €18.69M) in Series B funding.
Sunrise believes everyone should have a sleep test at least once in their lives. That’s why the startup is reimagining sleep apnoea detection.
Basel, Switzerland-based Noema Pharma, a clinical-stage biotech company, announced on Tuesday that it has raised CHF 103M (approximately €103.5M) in an oversubscribed Series B round of funding co-led by European healthcare-focused investment firms Forbion and Jeito Capital.
Siilo’s platform allows healthcare professionals to seek advice and collaborate on patient cases with their trusted network – wherever they are at the time.